Evidence map›Paper›PMID 35045881›Full record

ArticleCardiovascular ultrasound2022

Pilot study on the value of echocardiography combined with lung ultrasound to evaluate COVID-19 pneumonia.

Jing Han, Xi Yang, Wei Xu, Ronghua Jin, Weiyuan Liu, Lei Ding, Sha Meng, Yuan Zhang, Jin Li, Ying Zheng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular ultrasound, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Predictors of B-line count in hospitalized patients with COVID-19.Frontiers in cardiovascular medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Jing Han *Ultrasound and Functional Diagnosis Center, Beijing You An Hospital, Capital Medical University, Beijing, 100069, China.
Xi Yang *Department of ultrasound, Hanyang Hospital Affiliated to Wuhan University of science and technology, Wuhan, 430050, China.
Wei XuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
Ronghua JinBeijing You An Hospital, Capital Medical University, Beijing, 100069, China.
Weiyuan LiuUltrasound and Functional Diagnosis Center, Beijing You An Hospital, Capital Medical University, Beijing, 100069, China.
Lei DingUltrasound and Functional Diagnosis Center, Beijing You An Hospital, Capital Medical University, Beijing, 100069, China.
Sha MengDepartment of Science and Technology Department, Beijing You An Hospital, Capital Medical University, Beijing, 100069, China.
Yuan ZhangUltrasound and Functional Diagnosis Center, Beijing You An Hospital, Capital Medical University, Beijing, 100069, China.
Jin LiDepartment of Ultrasound, Beijing Hospital of Chinese Traditional and Western Medicine, Beijing, 100069, China.
Ying ZhengUltrasound and Functional Diagnosis Center, Beijing You An Hospital, Capital Medical University, Beijing, 100069, China.
Haowen LiUltrasonography, China Aerospace Science & Industry Corporation 731 Hospital, Beijing, 100074, China.
Fankun MengUltrasound and Functional Diagnosis Center, Beijing You An Hospital, Capital Medical University, Beijing, 100069, China. mengfankun@ccmu.edu.cn.
Beijing YouAn Hospital · CNBeijing Hospital of Traditional Chinese Medicine · CNCapital Medical University · CNChina Aerospace Science and Industry Corporation (China) · CNPeking University · CNWuhan University of Science and Technology · CN

Funding

Ministry of Human Resources and Social Security 2020YFC0844900
6 · The paper itself

Abstract

backgroundThis study aimed to investigate the relationship between echocardiography results and lung ultrasound score (LUS) in coronavirus disease 2019 (COVID-19) pneumonia patients and evaluate the impact of the combined application of these techniques in the evaluation of COVID-19 pneumonia.

methodsHospitalized COVID-19 pneumonia patients who underwent daily lung ultrasound and echocardiography were included in this study. Patients with tricuspid regurgitation within three days of admission were enrolled. Moreover, the correlation and differences between their pulmonary artery pressure (PAP) and LUS on days 3, 8, and 13 were analyzed. The inner diameter of the pulmonary artery root as well as the size of the atria and ventricles were also considered.

resultsThe PAP on days 3, 8, and 13 of hospitalization was positively correlated with the LUS (r = 0.448, p = 0.003; r = 0.738, p < 0.001; r = 0.325, p = 0.036, respectively). On day 8, the values of both PAP and LUS were higher than on days 3 and 13 (p < 0.01). Similarly, PAP and LUS were significantly increased in 92.9% (39/42) and 90.5% (38/42) of patients, respectively, and at least one of these two values was positive in 97.6% (41/42) of cases. The inner diameters of the right atrium, right ventricle, and pulmonary artery also differed significantly from their corresponding values on days 3 and 13 (p < 0.05).

conclusionsPAP is positively correlated with LUS in COVID-19 pneumonia. The two values could be combined for a more precise assessment of disease progression and recovery status.

Indexed as

COVID-19PneumoniaEchocardiographyHumansLungPilot ProjectsSARS-CoV-2UltrasonographyCOVID-19EchocardiographyLung ultrasound scorePulmonary arterial pressure

Identifiers

PMID35045881
PMCPMC8767359
OpenAlexW4206818040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.